Used in the synthesis of pharmaceutical intermediates, particularly in the development of dopamine receptor agonists. It serves as a chiral building block in the preparation of drugs targeting neurological disorders such as Parkinson’s disease and hyperprolactinemia. Its structural configuration supports high receptor selectivity, enhancing the efficacy and reducing side effects of the final drug product. Commonly employed in research settings for optimizing asymmetric synthesis routes and improving pharmacokinetic profiles of active pharmaceutical ingredients.